von Herrath M - Search Results

1

Mucosal exposure to antigen: cause or cure of type 1 diabetes?

Fousteri G, von Herrath M, Bresson D. Fousteri G, et al. Among authors: von herrath m. Curr Diab Rep. 2007 Apr;7(2):91-8. doi: 10.1007/s11892-007-0017-3. Curr Diab Rep. 2007. PMID: 17425912 Review.

2

Minimal impact of a de novo-expressed beta-cell autoantigen on spontaneous diabetes development in NOD mice.

Martinic MM, Juedes AE, Bresson D, Homann D, Skak K, Huber C, Ling E, Ejrnaes M, Wolfe T, Togher L, Christen U, von Herrath MG. Martinic MM, et al. Among authors: von herrath mg. Diabetes. 2007 Apr;56(4):1059-68. doi: 10.2337/db05-0062. Diabetes. 2007. PMID: 17395746

3

Antigen-specific induction of regulatory T cells for type 1 diabetes therapy.

Filippi C, Bresson D, von Herrath M. Filippi C, et al. Among authors: von herrath m. Int Rev Immunol. 2005 Sep-Dec;24(5-6):341-60. doi: 10.1080/08830180500371116. Int Rev Immunol. 2005. PMID: 16318986 Review.

4

Progress in the development of immune-based therapies for type 1 diabetes mellitus.

von Herrath M, Rottembourg D, Bresson D. von Herrath M, et al. BioDrugs. 2006;20(6):341-50. doi: 10.2165/00063030-200620060-00004. BioDrugs. 2006. PMID: 17176121 Review.

5

Rational development of antigen-specific therapies for type 1 diabetes.

Fousteri G, Bresson D, von Herrath M. Fousteri G, et al. Among authors: von herrath m. Adv Exp Med Biol. 2007;601:313-9. doi: 10.1007/978-0-387-72005-0_34. Adv Exp Med Biol. 2007. PMID: 17713020 Review.

6

First-trimester human fetal pancreas transplantation for type 1 diabetes treatment: an alternative approach for achieving long-term graft survival?

Fousteri G, von Herrath M. Fousteri G, et al. Among authors: von herrath m. Diabetes. 2008 Mar;57(3):525-6. doi: 10.2337/db07-1409. Diabetes. 2008. PMID: 18305145 No abstract available.

7

Resuscitating adaptive Tregs with combination therapies?

Bresson D, von Herrath M. Bresson D, et al. Among authors: von herrath m. Novartis Found Symp. 2008;292:50-60; discussion 60-7, 122-9, 202-3. doi: 10.1002/9780470697405.ch5. Novartis Found Symp. 2008. PMID: 19203092

8

Virtual optimization of nasal insulin therapy predicts immunization frequency to be crucial for diabetes protection.

Fousteri G, Chan JR, Zheng Y, Whiting C, Dave A, Bresson D, Croft M, von Herrath M. Fousteri G, et al. Among authors: von herrath m. Diabetes. 2010 Dec;59(12):3148-58. doi: 10.2337/db10-0561. Epub 2010 Sep 23. Diabetes. 2010. PMID: 20864513 Free PMC article.

9

Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment.

Bresson D, Fousteri G, Manenkova Y, Croft M, von Herrath M. Bresson D, et al. Among authors: von herrath m. J Autoimmun. 2011 Dec;37(4):342-51. doi: 10.1016/j.jaut.2011.10.001. Epub 2011 Nov 6. J Autoimmun. 2011. PMID: 22063316 Free PMC article.

10

Moving towards efficient therapies in type 1 diabetes: to combine or not to combine?

Bresson D, von Herrath M. Bresson D, et al. Among authors: von herrath m. Autoimmun Rev. 2007 Apr;6(5):315-22. doi: 10.1016/j.autrev.2006.09.013. Epub 2006 Oct 18. Autoimmun Rev. 2007. PMID: 17412305 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

337 results

Search Page

Filters